{"id":10490,"date":"2026-05-19T04:41:53","date_gmt":"2026-05-19T09:41:53","guid":{"rendered":"https:\/\/www.absglobal.com\/uk\/?p=10490"},"modified":"2026-05-19T04:43:22","modified_gmt":"2026-05-19T09:43:22","slug":"abs-surpasses-30-global-genotyping-growth","status":"publish","type":"post","link":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/","title":{"rendered":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion"},"content":{"rendered":"\n<p><em>Program continues to scale worldwide, reinforcing a more data-driven and results-oriented approach in livestock production<\/em><\/p>\n\n\n\n<p>ABS Global has surpassed 30% growth in commercial genotyping volumes in just 10 months. &nbsp;This expansion is largely driven by the global growth of GENEadvance\u00ae, a program that integrates genomics into a comprehensive genetic improvement strategy. <em>This acceleration in global genotyping goes beyond internal scale for ABS<\/em>&nbsp;\u2014 it directly enhances the value delivered to customers by strengthening the depth and reliability of the data behind every recommendation. A broader dataset enables GENEadvance to generate more precise predictions, reduce uncertainty in genetic decisions, and drive greater consistency of results in the field. In practical terms, this translates into more confident decision-making, better alignment with production goals, and faster, more predictable genetic progress.<\/p>\n\n\n\n<p>GENEadvance combines genomic data, dedicated technical advisory, and proprietary genetics to develop customised plans aligned with each customer\u2019s goals. Within this framework, genotyping is no longer an isolated tool, but part of a broader, structured decision-making process.<\/p>\n\n\n\n<p>\u201cThe producer defines how many heifers they want to produce in the next generation and the traits they are targeting. From there, we build a complete genetic strategy to consistently deliver on those objectives,\u201d says Juan Cainzos, GENEadvance Product Line Manager.<\/p>\n\n\n\n<p>Within this process, genomics plays a central role: mapping the herd, guiding the development of customised indices, and validating results over time. The structured use of data enables greater predictability and accelerates genetic progress, reducing variability and improving overall productivity.<\/p>\n\n\n\n<p>\u201cThe growth in genotyping clearly reflects market confidence in the quality of our data and in ABS\u2019s ability to deliver results. It marks a consistent shift toward a more objective, data-driven livestock industry, where decisions are based on solid information and focused on outcomes,\u201d says Matthew McClure, Product Development Manager.<\/p>\n\n\n\n<p>Learn more about <a href=\"https:\/\/www.absglobal.com\/uk\/geneadvance\/\">GENEadvance<\/a> and how genomics is transforming genetic decision making.<\/p>\n\n\n\n\t<h2 class=\"has-text-align-center is-style-underline wp-block-heading\" id=\"fyr-form\">Find Your ABS Representative<\/h2>\n\n    <div class=\"entry-content\" style=\"margin-top: 10px;\">\n        <iframe id=\"fyrFormIframe\" src=\"https:\/\/intranet-latam.absglobal.com\/api\/fyr\/form?country=GB%2CWA%2CND%2CSF&#038;source_url=https%3A%2F%2Fwww.absglobal.com%2Fuk%2Fabs-surpasses-30-global-genotyping-growth%2F\" width=\"100%\" style=\"border: none; overflow: hidden;\"><\/iframe>\n    <\/div>\n\n    <script>\n    window.addEventListener(\"message\", function(event) {\n        if (event.origin !== \"https:\/\/intranet-latam.absglobal.com\") return;\n        var iframe = document.getElementById(\"fyrFormIframe\");\n        if (iframe && event.data.height) {\n            var height = event.data.height + 100;\n            iframe.style.height = height + \"px\";\n        }\n    }, false);\n    <\/script>\n\n    \n","protected":false},"excerpt":{"rendered":"<p>Program continues to scale worldwide, reinforcing a more data-driven and results-oriented approach in livestock production ABS Global has surpassed 30% growth in commercial genotyping volumes in just 10 months. &nbsp;This expansion is largely driven by the global growth of GENEadvance\u00ae, a program that integrates genomics into a comprehensive genetic improvement strategy. This acceleration in global [&hellip;]<\/p>\n","protected":false},"author":11000,"featured_media":10491,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[50],"tags":[],"abs_type":[],"abs_industry":[],"class_list":["post-10490","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genetics"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.6 (Yoast SEO v25.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion - ABS Global UK<\/title>\n<meta name=\"description\" content=\"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion\" \/>\n<meta property=\"og:description\" content=\"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"ABS Global UK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GenusABSUK\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-19T09:41:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-19T09:43:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2429\" \/>\n\t<meta property=\"og:image:height\" content=\"1940\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"rebecca.dulson@genusplc.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rebecca.dulson@genusplc.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/\",\"url\":\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/\",\"name\":\"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion - ABS Global UK\",\"isPartOf\":{\"@id\":\"https:\/\/www.absglobal.com\/uk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png\",\"datePublished\":\"2026-05-19T09:41:53+00:00\",\"dateModified\":\"2026-05-19T09:43:22+00:00\",\"description\":\"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#primaryimage\",\"url\":\"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png\",\"contentUrl\":\"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png\",\"width\":2429,\"height\":1940},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.absglobal.com\/uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.absglobal.com\/uk\/#website\",\"url\":\"https:\/\/www.absglobal.com\/uk\/\",\"name\":\"ABS Global UK\",\"description\":\"Profit From Genetic Progress\",\"publisher\":{\"@id\":\"https:\/\/www.absglobal.com\/uk\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.absglobal.com\/uk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.absglobal.com\/uk\/#organization\",\"name\":\"ABS Global UK\",\"url\":\"https:\/\/www.absglobal.com\/uk\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.absglobal.com\/uk\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2020\/03\/cropped-genu-abs.png\",\"contentUrl\":\"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2020\/03\/cropped-genu-abs.png\",\"width\":2542,\"height\":1080,\"caption\":\"ABS Global UK\"},\"image\":{\"@id\":\"https:\/\/www.absglobal.com\/uk\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/GenusABSUK\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion - ABS Global UK","description":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/","og_locale":"en_GB","og_type":"article","og_title":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion","og_description":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion.","og_url":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/","og_site_name":"ABS Global UK","article_publisher":"https:\/\/www.facebook.com\/GenusABSUK\/","article_published_time":"2026-05-19T09:41:53+00:00","article_modified_time":"2026-05-19T09:43:22+00:00","og_image":[{"width":2429,"height":1940,"url":"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png","type":"image\/png"}],"author":"rebecca.dulson@genusplc.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rebecca.dulson@genusplc.com","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/","url":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/","name":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion - ABS Global UK","isPartOf":{"@id":"https:\/\/www.absglobal.com\/uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#primaryimage"},"image":{"@id":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png","datePublished":"2026-05-19T09:41:53+00:00","dateModified":"2026-05-19T09:43:22+00:00","description":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion.","breadcrumb":{"@id":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#primaryimage","url":"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png","contentUrl":"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png","width":2429,"height":1940},{"@type":"BreadcrumbList","@id":"https:\/\/www.absglobal.com\/uk\/abs-surpasses-30-global-genotyping-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.absglobal.com\/uk\/"},{"@type":"ListItem","position":2,"name":"ABS surpasses 30% global genotyping growth, driven by GENEadvance expansion"}]},{"@type":"WebSite","@id":"https:\/\/www.absglobal.com\/uk\/#website","url":"https:\/\/www.absglobal.com\/uk\/","name":"ABS Global UK","description":"Profit From Genetic Progress","publisher":{"@id":"https:\/\/www.absglobal.com\/uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.absglobal.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.absglobal.com\/uk\/#organization","name":"ABS Global UK","url":"https:\/\/www.absglobal.com\/uk\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.absglobal.com\/uk\/#\/schema\/logo\/image\/","url":"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2020\/03\/cropped-genu-abs.png","contentUrl":"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2020\/03\/cropped-genu-abs.png","width":2542,"height":1080,"caption":"ABS Global UK"},"image":{"@id":"https:\/\/www.absglobal.com\/uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/GenusABSUK\/"]}]}},"jetpack_featured_media_url":"https:\/\/www.absglobal.com\/uk\/wp-content\/uploads\/sites\/14\/2026\/05\/PHOTO_1.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/posts\/10490"}],"collection":[{"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/users\/11000"}],"replies":[{"embeddable":true,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/comments?post=10490"}],"version-history":[{"count":4,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/posts\/10490\/revisions"}],"predecessor-version":[{"id":10495,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/posts\/10490\/revisions\/10495"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/media\/10491"}],"wp:attachment":[{"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/media?parent=10490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/categories?post=10490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/tags?post=10490"},{"taxonomy":"abs_type","embeddable":true,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/abs_type?post=10490"},{"taxonomy":"abs_industry","embeddable":true,"href":"https:\/\/www.absglobal.com\/uk\/wp-json\/wp\/v2\/abs_industry?post=10490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}